MarginsXMarginsX
Home › Markets › Health Care › IXHL

Incannex Healthcare Inc. (IXHL)

IXHL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.93
-2.03% on the day
Market cap
$24.2M
Nano cap
Revenue · 2026
$0
-100.0% on 2025
Net income · 2026
-$19.3M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2026-06-30, https://www.sec.gov/Archives/edgar/data/1873875/000162828026063506/0001628280-26-063506-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-06-30.

Profile

FieldValue
TickerIXHL on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryAustralia
IPO yearNot reported by the screener
SEC CIK0001873875
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2026

LineValue
Revenue$0
Net income-$19.3M
Operating income-$23.0M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growth-100.0%
Cash$67.7M
Total assets$73.0M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
257.4 months
$68.3M cash at September 30, 2026
Share count, 1 year
+8.7%
2025-11-14 to 2026-11-09 · +2271.2% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$68.3M cash; operating cash flow -$796K a quarter.Report 2026-09-30
Shares outstanding12,546,030 (2026-11-09); 346,225,507 a year earlier; 15,873,113 three years earlier. 1y figure adjusted for split (1-for-30 overall); 3y figure adjusted for split (1-for-30 overall).Cover page 2026-11-09
Reverse splits, 3 years1; latest 1-for-30 on 2026-02-27Source 2026-02-27
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-03-12
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorGrant Thornton Audit Pty Ltd, Perth, AustraliaPCAOB Form AP 2026-10-02
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-09-30
$0-$1.9M$521K$68.3MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2026
2026-06-30
Not filed-$2.5M$3.4M$67.7MNo debt tags$010-K 2026-09-25
Q3 2026
2026-03-31
Not filed-$3.9M-$2.5M$74.5MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q2 2026
2025-12-31
Not filed-$6.5M-$4.6M$68.9MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q1 2026
2025-09-30
$0-$6.4M-$9.2M$73.3MNo debt tags$12K10-Q 2026-11-12
Q4 2025
2025-06-30
$0-$31.6M-$1.5M$15.0MNo debt tags$86K10-K 2026-09-25
Q3 2025
2025-03-31
$0-$4.0M-$3.2M$6.7M$1.4MNeeds four quarters10-Q 2025-05-15
Q2 2025
2024-12-31
$12K-$5.9M-$5.6M$2.1M$3.8MNeeds four quarters10-Q 2025-02-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B52026-03-12
Latest annual report10-K2026-09-25
Latest quarterly / interim10-Q2026-11-12
Latest current report
CURRENT REPORT
8-K2026-09-09
Latest proxy
DEFINITIVE ADDITIONAL MATERIALS
DEFA14A2026-10-28

Source: SEC EDGAR submissions feed, 267 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-12.1%
1 month-32.3%
3 months-37.7%
Year to date-81.7%
1 year-81.6%
From 52-week high-86.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
BYSIBeyondSpring Inc.$0.5788-3.73%$23.8M
FLNAFilana Therapeutics Inc.$0.4700+10.56%$23.6M
GRDXGridAI Technologies Corp.$3.30-11.76%$23.5M
IMMPImmutep Limited$3.40-2.30%$25.1M
CRVOCervoMed Inc.$1.67-1.18%$25.3M
ABVCABVC BioPharma Inc.$0.9400+3.30%$25.4M
EDSAEdesa Biotech Inc. Common Shares$1.89-2.58%$25.5M
LITSLite Strategy Inc.$0.8565+1.16%$25.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier